Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150


Change in the characteristics of ferritin induces iron imbalance in prion disease affected brains.

Singh A, Qing L, Kong Q, Singh N.

Neurobiol Dis. 2012 Mar;45(3):930-8. doi: 10.1016/j.nbd.2011.12.012. Epub 2011 Dec 11.


Abnormal brain iron homeostasis in human and animal prion disorders.

Singh A, Isaac AO, Luo X, Mohan ML, Cohen ML, Chen F, Kong Q, Bartz J, Singh N.

PLoS Pathog. 2009 Mar;5(3):e1000336. doi: 10.1371/journal.ppat.1000336. Epub 2009 Mar 13.


Prion protein modulates cellular iron uptake: a novel function with implications for prion disease pathogenesis.

Singh A, Mohan ML, Isaac AO, Luo X, Petrak J, Vyoral D, Singh N.

PLoS One. 2009;4(2):e4468. doi: 10.1371/journal.pone.0004468. Epub 2009 Feb 12. Erratum in: PLoS ONE. 2009;4(2). doi: 10.1371/annotation/194f4e44-20f0-48eb-bbe9-14e21d18909b.


Paradoxical role of prion protein aggregates in redox-iron induced toxicity.

Das D, Luo X, Singh A, Gu Y, Ghosh S, Mukhopadhyay CK, Chen SG, Sy MS, Kong Q, Singh N.

PLoS One. 2010 Jul 6;5(7):e11420. doi: 10.1371/journal.pone.0011420.


Protease-resistant human prion protein and ferritin are cotransported across Caco-2 epithelial cells: implications for species barrier in prion uptake from the intestine.

Mishra RS, Basu S, Gu Y, Luo X, Zou WQ, Mishra R, Li R, Chen SG, Gambetti P, Fujioka H, Singh N.

J Neurosci. 2004 Dec 15;24(50):11280-90.


Iron content of ferritin modulates its uptake by intestinal epithelium: implications for co-transport of prions.

Bhupanapadu Sunkesula SR, Luo X, Das D, Singh A, Singh N.

Mol Brain. 2010 Apr 29;3:14. doi: 10.1186/1756-6606-3-14.


Co-existence of scrapie prion protein types 1 and 2 in sporadic Creutzfeldt-Jakob disease: its effect on the phenotype and prion-type characteristics.

Cali I, Castellani R, Alshekhlee A, Cohen Y, Blevins J, Yuan J, Langeveld JP, Parchi P, Safar JG, Zou WQ, Gambetti P.

Brain. 2009 Oct;132(Pt 10):2643-58. doi: 10.1093/brain/awp196. Epub 2009 Sep 4.


Early appearance but lagged accumulation of detergent-insoluble prion protein in the brains of mice inoculated with a mouse-adapted Creutzfeldt-Jakob disease agent.

Nakaoke R, Sakaguchi S, Atarashi R, Nishida N, Arima K, Shigematsu K, Katamine S.

Cell Mol Neurobiol. 2000 Dec;20(6):717-30.


De novo generation of infectious prions in vitro produces a new disease phenotype.

Barria MA, Mukherjee A, Gonzalez-Romero D, Morales R, Soto C.

PLoS Pathog. 2009 May;5(5):e1000421. doi: 10.1371/journal.ppat.1000421. Epub 2009 May 15. Erratum in: PLoS Pathog. 2013 Mar;9(3). doi:10.1371/annotation/4b55946a-edb5-4feb-aeb5-2ee160394d17.


Identification of distinct N-terminal truncated forms of prion protein in different Creutzfeldt-Jakob disease subtypes.

Zanusso G, Farinazzo A, Prelli F, Fiorini M, Gelati M, Ferrari S, Righetti PG, Rizzuto N, Frangione B, Monaco S.

J Biol Chem. 2004 Sep 10;279(37):38936-42. Epub 2004 Jul 9.


Gerstmann-Sträussler-Scheinker disease and "anchorless prion protein" mice share prion conformational properties diverging from sporadic Creutzfeldt-Jakob disease.

Zanusso G, Fiorini M, Ferrari S, Meade-White K, Barbieri I, Brocchi E, Ghetti B, Monaco S.

J Biol Chem. 2014 Feb 21;289(8):4870-81. doi: 10.1074/jbc.M113.531335. Epub 2014 Jan 7.


A traceback phenomenon can reveal the origin of prion infection.

Kobayashi A, Asano M, Mohri S, Kitamoto T.

Neuropathology. 2009 Oct;29(5):619-24. doi: 10.1111/j.1440-1789.2008.00973.x. Epub 2009 Jul 29.


Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C).

Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, Blevins J, Sy MS, Cohen M, Kong Q, Telling GC, Surewicz WK, Safar JG.

PLoS Pathog. 2012;8(8):e1002835. doi: 10.1371/journal.ppat.1002835. Epub 2012 Aug 2.


Re-assessment of PrP(Sc) distribution in sporadic and variant CJD.

Rubenstein R, Chang B.

PLoS One. 2013 Jul 3;8(7):e66352. doi: 10.1371/journal.pone.0066352. Print 2013.


Sc237 hamster PrPSc and Sc237-derived mouse PrPSc generated by interspecies in vitro amplification exhibit distinct pathological and biochemical properties in tga20 transgenic mice.

Yoshioka M, Imamura M, Okada H, Shimozaki N, Murayama Y, Yokoyama T, Mohri S.

Microbiol Immunol. 2011 May;55(5):331-40. doi: 10.1111/j.1348-0421.2011.00328.x.


Efficient in vitro amplification of a mouse-adapted scrapie prion protein.

Murayama Y, Yoshioka M, Yokoyama T, Iwamaru Y, Imamura M, Masujin K, Yoshiba S, Mohri S.

Neurosci Lett. 2007 Feb 21;413(3):270-3. Epub 2006 Dec 14.


In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.

Faburay B, Tark D, Kanthasamy AG, Richt JA.

Prion. 2014;8(6):393-403. doi: 10.4161/19336896.2014.983753.


MM2-thalamic Creutzfeldt-Jakob disease: neuropathological, biochemical and transmission studies identify a distinctive prion strain.

Moda F, Suardi S, Di Fede G, Indaco A, Limido L, Vimercati C, Ruggerone M, Campagnani I, Langeveld J, Terruzzi A, Brambilla A, Zerbi P, Fociani P, Bishop MT, Will RG, Manson JC, Giaccone G, Tagliavini F.

Brain Pathol. 2012 Sep;22(5):662-9. doi: 10.1111/j.1750-3639.2012.00572.x. Epub 2012 Feb 21.


Supplemental Content

Support Center